This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodman, M. T. Articles by Donlon, T. A. Search for Related Content PubMed PubMed Citation Articles by Goodman, M. T. Articles by Donlon, T. A.

Association of Methylenetetrahydrofolate Reductase Polymorphism C677T and Dietary Folate with the Risk of Cervical Dysplasia¹

Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813 [M. T. G., K. M., B. H., L. R. W., L. L. M., S. M., T. A. D.]; Department of Pathology, Kapiolani Medical Center for Women and Children, Honolulu, Hawaii 96826 [J. K.]; Queen Emma Clinic, The Queen’s Medical Center, Honolulu, Hawaii 96813 [C. C. B.]; Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111 [J. S.]

Epidemiological studies have been inconsistent regarding a role for folate in the etiology of cervical dysplasia. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, which is involved in the methylation of homocysteine to methionine. A common variant of this enzyme, resulting from a 677CT (AlaVal) substitution in the gene, has been shown to have reduced activity and is associated with mild hyperhomocysteinemia. A multiethnic case-control study was used to examine the association of dietary folate and MTHFR genotype with the odds ratios (ORs) for cervical dysplasia among women identified from several clinics on Oahu, Hawaii, between 1992 and 1996. We collected blood samples for DNA extraction, cervical smears for cytological diagnosis, exfoliated cervical cells for human papillomavirus (HPV) DNA testing, and personal interviews from 150 women with squamous intraepithelial lesions (SILs) and from 179 women with cytologically normal (Pap) smears. We found a positive, monotonic trend (P = 0.02) in the ORs for cervical SILs associated with the number of variant MTHFR T alleles, after multivariate adjustment. Women with the heterozygous CT genotype had twice the risk of cervical SILs [OR, 2.0; 95% confidence interval (CI), 1.1–3.7], and women with the homozygous TT genotype had almost three times the risk of SILs (OR, 2.9; 95% CI, 1.0–8.8) compared to women with the homozygous MTHFR CC genotype. The dietary intakes of folate, vitamin B₆, and vitamin B₁₂ were inversely related to the ORs for cervical SILs, after adjustment for HPV DNA and other confounders. The OR among women in the highest quartile compared with women in the lowest quartile of folate intake was 0.3 (95% CI, 0.1–0.7; P for trend = 0.002). Women with the variant T allele and folate intakes below the median were at significantly elevated risk of cervical SILs (OR, 5.0; 95% CI, 2.0–12.2) compared to women with CC alleles and folate intakes above the median. HPV infection was a strong risk factor for cervical dysplasia, particularly among women with the variant T allele (OR, 46.6; 95% CI, 15.9–136.2). All associations of MTHFR genotype with the ORs for cervical SILs were independent of other risk factors under study. These findings suggest that the MTHFR T allele and reduced dietary folate may increase the risk for cervical SILs.

This article has been cited by other articles:

				H. J. Powers Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer J. Nutr., December 1, 2005; 135(12): 2960S - 2966S. [Abstract] [Full Text] [PDF]

				S. Narayanan, J. McConnell, J. Little, L. Sharp, C. J. Piyathilake, H. Powers, G. Basten, and S. J. Duthie Associations between Two Common Variants C677T and A1298C in the Methylenetetrahydrofolate Reductase Gene and Measures of Folate Metabolism and DNA Stability (Strand Breaks, Misincorporated Uracil, and DNA Methylation Status) in Human Lymphocytes In vivo Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1436 - 1443. [Abstract] [Full Text] [PDF]

				J. Lin, M. R. Spitz, Y. Wang, M. B. Schabath, I. P. Gorlov, L. M. Hernandez, P. C. Pillow, H. B. Grossman, and X. Wu Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study Carcinogenesis, September 1, 2004; 25(9): 1639 - 1647. [Abstract] [Full Text] [PDF]

				M. S. Cicek, N. L. Nock, L. Li, D. V. Conti, G. Casey, and J. S. Witte Relationship between Methylenetetrahydrofolate Reductase C677T and A1298C Genotypes and Haplotypes and Prostate Cancer Risk and Aggressiveness Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1331 - 1336. [Abstract] [Full Text] [PDF]

				M. Kimura, K. Umegaki, M. Higuchi, P. Thomas, and M. Fenech Methylenetetrahydrofolate Reductase C677T Polymorphism, Folic Acid and Riboflavin Are Important Determinants of Genome Stability in Cultured Human Lymphocytes J. Nutr., January 1, 2004; 134(1): 48 - 56. [Abstract] [Full Text] [PDF]

				S. S. Wang and A. Hildesheim Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 35 - 40. [Abstract] [Full Text] [PDF]

				B. T. Heijmans, J. M. A. Boer, H. E. D. Suchiman, C. J. Cornelisse, R. G. J. Westendorp, D. Kromhout, E. J. M. Feskens, and P. E. Slagboom A Common Variant of the Methylenetetrahydrofolate Reductase Gene (1p36) Is Associated with an Increased Risk of Cancer Cancer Res., March 15, 2003; 63(6): 1249 - 1253. [Abstract] [Full Text] [PDF]